California Research Agency Not Ruling Out Spending Nearly $1 Billion Annually for Stem Cell/Gene Therapy Awards in the Golden State

The “father” of the program calls for doubling current spending levels

CIRM has had only three chairs in its 21-year life. Bob Klein, its first, is on the right. Vito Imbasciani, its current chair, is center. Jonthan Thomas, on the left, was the second and is now the CIRM CEO. 2023 photo by the California Stem Cell Report

California’s ambitious stem cell and gene therapy program is not saying no to a proposal to double its …